Latest Dilution News

Page 3 of 323
Dotz Nano has repriced its A$2 million placement after CEO and director Nati Harpaz resigned for health reasons, increasing the proposed share issue while adding more generous attaching options. The company has also clarified that its September quarterly report described commitments as a completed raise even though no shares or funds had then changed hands.
Victor Sage
Victor Sage
18 Nov 2026
Yowie Group has appointed GBA Capital and Boston Global to lead a proposed A$2.5 million placement, with the company’s shares still suspended from ASX trading. The raising is intended to support a shift towards a multi-brand confectionery business and help satisfy the conditions for a possible reinstatement.
Victor Sage
Victor Sage
18 Nov 2026
EPX is seeking up to A$1.7 million through a placement and partially underwritten entitlement offer, with the funds aimed at installing new revenue-generating opportunities and supporting working capital. Up to A$500,000 may instead be needed for a disputed UAE employment matter.
Sophie Babbage
Sophie Babbage
18 Nov 2026
Gorilla Gold Mines has secured firm commitments for a A$60 million placement, clearing the minimum funding hurdle for its proposed Cosmos acquisition while giving the company cash to pursue a large Western Australian drilling program. The deal brings resources investor Tembo Capital onto the register, but shareholder approval and other conditions still stand between Gorilla and completion.
Maxwell Dee
Maxwell Dee
18 Nov 2026
Helix Resources has agreed to acquire five Pilbara gold tenements and applications for A$150,000 in cash and A$500,000 in shares. The deal expands its exploration pipeline, but two tenements remain applications and no new geological results or resources have been reported.
Maxwell Dee
Maxwell Dee
18 Nov 2026
NVIDIA delivered record fiscal third-quarter revenue of US$115.8 billion, with Data Center sales rising 110% year on year. The company expects another record quarter, but its outlook excludes China compute revenue and comes alongside US$518 billion of commitments and up to US$118 billion of guarantee exposure.
Sophie Babbage
Sophie Babbage
18 Nov 2026
Auric Mining can now proceed with its proposed share purchase plan at A$0.185 per share, matching the price offered to placement investors despite sitting 21.5% below the relevant five-day VWAP. The waiver also allows directors and related parties to participate, subject to equal-treatment safeguards.
Maxwell Dee
Maxwell Dee
18 Nov 2026
Atmos Energy has replaced its existing at-the-market share sale programme with a new facility capable of issuing up to US$1.7 billion of common stock. No shares have been sold under the new arrangement, but the programme gives the gas distributor another substantial source of funding for its infrastructure spending.
Maxwell Dee
Maxwell Dee
18 Nov 2026
Nike has laid out a five-year recovery plan targeting US$5 billion in incremental revenue by fiscal 2031, but the near-term picture remains difficult. Fiscal 2027 revenue is still expected to fall by a high-single-digit percentage, with restructuring costs weighing on earnings.
Logan Eniac
Logan Eniac
18 Nov 2026
Disney finished fiscal 2026 with strong revenue, adjusted earnings and cash-flow growth, while signalling another year of expansion despite the loss of an extra reporting week. The company is also reshaping its segment reporting to put consumer products closer to its entertainment franchises.
Victor Sage
Victor Sage
17 Nov 2026
Home Depot is changing its top leadership team just as third-quarter sales and comparable-store growth accelerate. Richard McPhail will become CEO, while Ted Decker returns from medical leave to chair the board and the retailer trims its fiscal 2026 earnings outlook to modest growth.
Logan Eniac
Logan Eniac
17 Nov 2026
Vitrafy says it has moved from cryopreservation research into commercial execution, with 19 Guardion devices built, new US partnerships and $38.3 million in cash and term deposits. The next test is converting partner evaluations into recurring revenue after a planned FDA Class II listing in the coming weeks.
Victor Sage
Victor Sage
17 Nov 2026

Browse the archive

Full archive